Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer

Completed · Phase 2

Conditions studied: Gastric Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well irinotecan and cisplatin followed by surgery, floxuridine, and cisplatin work in treating patients with stomach cancer.

Key facts

Study ID

NCT00004103

Run by

NYU Langone Health

Starts

1998-07-01

Expected to finish

2009-06-01

Last updated by the study team

2011-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NYU Cancer Institute at New York University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.